FIELD: biotechnology.
SUBSTANCE: invention relates to attenuated tuberculosis mycobacteria. The strain of Mycobacterium tuberculosis BN is deposited in the state collection of pathogenic microorganisms and cell cultures "SCPM-Obolensk" under the assigned number B-9359 and can be used to model latent tuberculosis infection and develop an anti-tuberculosis vaccine.
EFFECT: invention provides a possibility of increasing the effectiveness of protection against tuberculosis.
1 cl, 5 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING MYCOBACTERIUM BOVIS BCG STRAINS IN REAL TIME FORMAT | 2018 |
|
RU2689801C1 |
| ANTITUBERCULOUS VACCINE | 2007 |
|
RU2443773C2 |
| COMPOSITIONS FOR USE AS A PREVENTIVE AGENT FOR PATIENTS WITH A RISK OF TB INFECTION OR AS A SECONDARY AGENT FOR THE TREATMENT OF PATIENTS WITH TB INFECTION | 2019 |
|
RU2778094C2 |
| RECOMBINANT PLASMID pAg85A-CBD, Escherichia coli [pREP4, pAg85A-CBD] STRAIN, CHIMERIC PROTEIN Ag85A-CBD AND THEIR APPLICATION | 2010 |
|
RU2429292C1 |
| RECOMBINANT PLASMID, Escherichia coli STRAIN, CHIMERIC PROTEIN AND THEIR APPLICATION | 2010 |
|
RU2422525C1 |
| MULTI-EPITOPE POLYPEPTIDE FOR IMMUNIZATION AGAINST MYCOBACTERIUM TUBERCULOSIS | 2023 |
|
RU2824195C1 |
| VACCINE COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF TUBERCULOSIS INFECTION AND GENETIC CONSTRUCTIONS FOR PREPARING ACTING COMPONENTS OF THIS COMPOSITION | 2003 |
|
RU2262351C1 |
| MYCOBACTERIUM TUBERCULOSIS VACCINE | 2009 |
|
RU2473365C1 |
| POLYANTIGENIC VACCINE FOR PREVENTING AND ADJUNCTIVE TREATMENT OF TUBERCULOSIS | 2019 |
|
RU2724896C1 |
| METHOD FOR OBTAINING VACCINE FOR TREATING TUBERCULOSIS AND OTHER INTRACELLULAR INFECTIOUS DISEASES AND VACCINE OBTAINED ACCORDING TO DECLARED METHOD | 2001 |
|
RU2262950C2 |
